Columbia Contrarian Core-I3COFYX

13F holders, Q4 2025 (December 31)
2holders
0new positions
0sold out
$39.93avg. 13F price*

At the end of Q4 2025, 2 institutions reported holding Columbia Contrarian Core-I3 (COFYX) in their 13F filings, unchanged from Q3 2025. 0 opened new positions and 0 sold out. The largest holders were First Merchants Corp. ($283K) and Coston, McIsaac & Partners ($46K).

Company
Columbia Contrarian Core-I3
CUSIP
19766M709
Latest filing quarter
Q2 2026

History

Number of 13F holders

012 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q1 2025: 1Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025Q4 2025: 2Q4 2025Q1 2026: 2Q1 2026Q2 2026: 2Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q3 2025 → Q4 2025: 74 shares bought, net +74 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

First Merchants Corp. 0.01% No change 7,094 $283K
Coston, McIsaac & Partners 0.01% Add +6.8% 1,158 $46K

"% of holder's portfolio" is COFYX's weight in each manager's 13F, not the share of Columbia Contrarian Core-I3 the manager owns.